Our Company

Founded in 2016, Covar Pharmaceuticals specializes in guiding clients through the early development process, typically starting as early as pre-development through to conventional/hybrid Phase I and dose ranging Phase II studies.

Our core belief is that we are a product development company first and foremost. Every molecule is a unique technology and deserves a unique development strategy.

Our Management Team consists of colleagues who have worked together more than three decades across a range of senior positions in big pharma, global CDMOs, and regulatory/technical consulting. In total our management team possesses well over a century of industry experience (and counting).

Our Management Team draws from a deep well of experience not just in early development, but also late phase development and commercialization (including blockbuster products). We also insist that Covar retain the agility and cost-awareness of a boutique CDMO in order to provide clients what we believe to be the best of both worlds.

Covar espouses an integrated team approach that puts the success and timelines of our clients as the first priority. We pride ourselves in our ability to manage and execute complex development programs at essentially all stages of the early development process.

Our product development services are provided from our Drug Establishment Licensed facility (no. 3‑002783‑A) in Mississauga, Canada.